- Flagship Ventures participated in 6 rounds in the past year.
- The total disclosed amount of capital deployed in those rounds was $416,000,000 (averaging $69,333,333 per round).
- KSQ Therapeutics, Inc.: Venture capital ($76M)
- Indigo: Venture capital (Series D) ($156M)
- Evelo Therapeutics: Venture capital (Series B) ($50M)
- Polaris Partners
- General Catalyst Partners
- ARCH Venture Partners
Want to see the complete list?